Pediatric Nuclear Medicine Dosing Explained

Q: How is administered activity determined for children in nuclear medicine?

Administered activity in pediatric nuclear medicine is scaled to body weight using a per-kilogram factor specific to each radiopharmaceutical, then constrained by a minimum activity (and sometimes a maximum). The North American consensus guidelines and the EANM pediatric dosage card provide these factors so that image quality is preserved while dose is minimized for the child's size.

Q: Why do pediatric protocols use a minimum administered activity?

A pure weight-based calculation would give very small infants an activity too low to produce diagnostic images in a reasonable acquisition time. A minimum administered activity ensures that even the smallest patients receive enough counts for an interpretable study, accepting a modestly higher dose per kilogram in exchange for a usable result.

Q: What are the North American consensus guidelines?

They are harmonized recommendations for pediatric administered radiopharmaceutical activities, first published in 2010 and updated in 2016 and 2024 under the Image Gently Alliance. They specify weight-based factors and minimum activities for common pediatric nuclear medicine and PET procedures and are the principal U.S. reference for pediatric dosing.

Q: What changed in the 2024 update of the guidelines?

According to the 2024 update, none of the 23 protocols from the 2016 version were removed, but nine were modified and six new protocols were added—five of them PET agents—reflecting the growing routine use of PET in children. The update addresses advances in imaging equipment, reconstruction, and the introduction of new radiopharmaceuticals.

Q: Are children more sensitive to radiation than adults?

Yes. Children are generally more radiosensitive than adults for stochastic effects, and they have a longer lifetime over which radiation-related effects can manifest. This is why pediatric dose optimization—administering the lowest activity consistent with a diagnostic study—is a central principle of pediatric nuclear medicine.

Q: Do the North American and European guidelines agree?

They were developed separately—the North American consensus guidelines and the EANM pediatric dosage card—but a joint working group harmonized them so that recommended activities are closely aligned for most procedures. Facilities should follow one consistent, current guideline and document their dosing methodology.

Q: Who is responsible for the administered activity in a pediatric study?

The authorized user is responsible for the dosage, supported by the nuclear medicine technologist who prepares and administers it and the medical physicist who helps establish and validate dosing protocols. Under 10 CFR Part 35, diagnostic dosages must be determined and documented, and therapy dosages require a written directive.

Pediatric nuclear medicine dosing scales administered activity to a child's body weight using radiopharmaceutical-specific factors, then enforces a minimum activity so even the smallest patients get a diagnostic study. The goal is to administer the lowest activity consistent with an interpretable image—because children are more radiosensitive than adults and have a longer lifetime for any radiation-related effects to manifest.¹²³

Getting pediatric dosing right is a genuinely physics-driven problem. Administer too little activity and the study is too noisy to interpret, forcing a repeat and a second dose. Administer an adult-sized activity to a small child and the dose per kilogram becomes indefensible. The North American consensus guidelines—first published in 2010, updated in 2016, and most recently updated in 2024 under the Image Gently Alliance—exist to resolve that tension with standardized, weight-based recommendations.¹²⁴ This guide explains the dosing methodology, walks through worked calculations, and lays out the regulatory framework.

Introduction

Children are not small adults. Their organ sizes, body composition, radiopharmaceutical biokinetics, and radiosensitivity all differ from adults, and those differences compound when deciding how much activity to administer. A neonate undergoing a renal study and an adolescent undergoing the same study can differ in weight by a factor of fifteen or more, and a single fixed activity cannot serve both well.³

For decades, pediatric administered activities were estimated with age- or weight-based fractions of the adult activity (the historical Webster and Clark rules), but these approaches were inconsistent between institutions and not grounded in modern imaging performance.¹ The result was wide, unjustified variation in pediatric dose. The North American consensus guidelines were created to replace that variation with harmonized, evidence-informed recommendations, and the parallel EANM Paediatric Dosage Card did the same in Europe; a joint working group later harmonized the two so that recommendations are closely aligned across continents.¹⁹¹⁰

Pediatric dose stewardship is a cornerstone of the Image Gently campaign and of every credible nuclear medicine quality program. DRPS supports pediatric and general nuclear medicine programs with PET/CT and nuclear medicine physics, protocol development, and radiation safety training across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

What "administered activity" means and why it is the lever

Administered activity is the amount of radiopharmaceutical activity, in megabecquerels (MBq) or millicuries (mCi), given to the patient. In diagnostic nuclear medicine, the administered activity is the primary determinant of both image quality (more activity generally means more detected counts and lower image noise) and patient radiation dose (more activity means more absorbed dose). Pediatric dosing is therefore an optimization problem: find the smallest activity that still yields a diagnostic study for that child's size and the specific procedure.¹³

This differs fundamentally from CT, where dose is governed by machine output settings. In nuclear medicine the "dose knob" is the activity drawn into the syringe, which makes a standardized, weight-based prescription the most effective optimization tool. For the imaging-quality side of that trade-off in PET specifically, see our guides to PET uptake time and SUV quantification.

Weight-based scaling with a minimum activity

The consensus methodology has two parts. First, a per-kilogram factor specific to each radiopharmaceutical is multiplied by the child's body weight. Second, that result is compared against a minimum administered activity, and the larger of the two is administered.¹² The minimum is essential: without it, a 3-kg infant scaled purely by weight would receive an activity too small to image in any reasonable acquisition time. The minimum guarantees a diagnostic study for the smallest patients, accepting a higher dose per kilogram as the price of an interpretable image.

Some procedures also impose a maximum administered activity (often the typical adult activity), so that a large adolescent is not given more than an adult would receive. The combination of a weight-based factor, a minimum, and sometimes a maximum is what produces a smooth, defensible dosing curve across the entire pediatric weight range.¹³

Dosing approaches compared

Approach	How activity is set	Strengths	Limitations
Fixed fraction of adult (Webster, Clark — historical)	Age- or weight-based fraction of adult activity	Simple arithmetic	Inconsistent between sites; not tied to image quality
Weight-based linear (North American consensus)	Per-kg factor × weight, with minimum (and sometimes maximum)	Balances image quality and dose; harmonized; widely adopted in U.S.	Requires a minimum-activity floor; per-agent factors must be kept current
EANM Paediatric Dosage Card	Baseline activity × weight-dependent multiplier by dose class	Internationally harmonized; smooth scaling	Class-based lookup adds complexity

The modern standard of care in North America is weight-based linear scaling per the consensus guidelines, harmonized with the EANM card.¹⁹¹⁰

Key Technical Principles

The dosing equation

The weight-based administered activity with a minimum can be written compactly. For a child of body mass $m$ (kg), a radiopharmaceutical-specific per-weight factor $k$ (MBq/kg), and a minimum administered activity $A_{min}$ (MBq):

A = max (k \cdot m, A_{min})

When a maximum $A_{ma x}$ is also specified, the prescription is bounded on both sides:

A = min (max (k \cdot m, A_{min}), A_{ma x})

Worked example: a bone scan in two children

Consider technetium-99m MDP for skeletal scintigraphy. The North American consensus guideline recommends a weight-based factor of approximately $k = 9.3 MBq/kg$ (0.25 mCi/kg) with a minimum administered activity on the order of $A_{min} = 37 MBq$ (1.0 mCi).¹² (Always confirm the exact value against the current guideline before clinical use; the values here illustrate the method.)

For an 18-kg child:

k \cdot m = 9.3 \frac{MBq}{kg} \times 18 kg = 167.4 MBq

Since $167.4 MBq > 37 MBq$ , the weight-based value governs and the administered activity is approximately 167 MBq (about 4.5 mCi).

For a 3-kg infant:

k \cdot m = 9.3 \frac{MBq}{kg} \times 3 kg = 27.9 MBq

Here $27.9 MBq < 37 MBq$ , so the minimum of 37 MBq (1.0 mCi) is administered instead. The infant receives a higher activity per kilogram than the older child, but that is the deliberate trade-off the minimum is designed to make: a diagnostic image rather than an uninterpretable, count-starved study that would have to be repeated.¹³

Why noise scales the way it does

The reason a minimum activity exists at all is rooted in counting statistics. In emission imaging, image noise is governed by the number of detected counts $N$ , and the relative noise scales as:

\frac{σ}{N} = \frac{N}{N} = \frac{1}{N}

Detected counts are proportional to administered activity, acquisition time, and detector sensitivity. If a weight-based activity for a tiny infant would yield too few counts, the relative noise becomes unacceptable unless acquisition time is extended impractically. Raising the activity to the minimum restores enough counts for a diagnostic signal-to-noise ratio. This counting-statistics floor is the physical justification for the minimum-activity rule.³

Representative consensus values

The table below shows representative per-weight factors and minimum activities for several common agents, to illustrate how the methodology varies by radiopharmaceutical. These are representative of the consensus guideline values; the current guideline should always be consulted for the operative numbers.¹²

Radiopharmaceutical	Procedure	Representative factor	Representative minimum
Tc-99m MDP	Skeletal scintigraphy	~9.3 MBq/kg (0.25 mCi/kg)	~37 MBq (1.0 mCi)
Tc-99m DMSA	Renal cortical imaging	~1.85 MBq/kg (0.05 mCi/kg)	~18.5 MBq (0.5 mCi)
Tc-99m MAG3	Renal dynamic imaging	~3.7 MBq/kg (0.10 mCi/kg)	~37 MBq (1.0 mCi)
F-18 FDG	Body PET (oncology)	~3.7–5.2 MBq/kg (0.10–0.14 mCi/kg)	~26 MBq (0.7 mCi)

The wide range of per-weight factors reflects the different imaging tasks, biokinetics, and acquisition modes of each agent. Accurate dispensing of these activities depends on a well-maintained dose calibrator; see our guide to dose calibrator quality control.

Clinical Impact

Standardized pediatric dosing produces three concrete clinical benefits: lower and more consistent dose, fewer repeat studies, and defensible documentation. When a practice adopts the consensus guidelines, the unjustified site-to-site variation in pediatric activity collapses toward a harmonized, optimized curve, so a child receives a comparable, appropriate dose regardless of which facility performs the study.¹³

The fewer-repeats benefit is easy to underestimate. A study that is too noisy to interpret is not merely a wasted dose—it is a doubled dose, because the child must return and be injected again. The minimum-activity rule is engineered precisely to prevent count-starved, non-diagnostic studies in small patients, so the guideline framework reduces repeats even as it lowers routine dose.¹

The 2024 update underscores how the clinical landscape is shifting toward PET. According to the 2024 update of the North American consensus guidelines, six new protocols were added—five of them PET agents, including Ga-68 DOTATATE, Ga-68 DOTATOC, and F-DOPA—reflecting the growing routine use of PET in children over the past decade.⁴ As pediatric PET grows, weight-based dosing of positron-emitting agents, combined with low-dose CT technique on the hybrid scanner, becomes central to keeping total study dose appropriate. The CT side of that equation is covered in our guide to pediatric CT dose optimization.

Practical Optimization Tips

Use a validated tool, not mental math

Adopt the SNMMI Pediatric Injected Activity Tool or an equivalent calculator rather than calculating activities by hand at the bench. A validated tool applies the current factors, minimums, and maximums consistently and reduces transcription errors.⁵
Lock the guideline version into your protocol. Document which guideline (and which year) your practice follows, and update protocols when a new version—such as the 2024 update—is released.⁴

Optimize the whole study, not just the activity

Pair low activity with modern reconstruction. Iterative and resolution-recovery reconstruction can preserve image quality at lower counts, supporting weight-based dose reduction.
Right-size the CT on hybrid systems. On SPECT/CT and PET/CT, the CT component can dominate total dose if not optimized for the child's size; apply pediatric CT technique deliberately.
Confirm acquisition time and uptake. Adequate counts depend on activity and time; extending acquisition modestly can offset a lower activity in cooperative patients.

Build dosing into your QA program

Validate dose-calibrator accuracy. Weight-based dosing is only as good as the activity measurement; a dose calibrator out of tolerance undermines every pediatric prescription.⁵
Audit administered activities periodically. Compare dispensed activities against the guideline to catch drift, and document the review.

Common pitfalls to avoid

Skipping the minimum activity, producing non-diagnostic studies in infants.
Applying an adult fixed activity to an adolescent without checking the weight-based result and any maximum.
Mixing guideline versions across technologists, producing inconsistent dosing.
Ignoring the CT contribution on hybrid imaging, where it can exceed the radiopharmaceutical dose.

Regulatory Considerations

Pediatric administered activity sits within the 10 CFR Part 35 framework for the medical use of byproduct material, even though the consensus guidelines themselves are professional recommendations rather than NRC regulations. Understanding both layers matters.

10 CFR Part 35 — Medical Use of Byproduct Material. Diagnostic dosages must be determined and documented before administration, and the authorized user is responsible for the dosage. Therapeutic administrations (for example, I-131 for pediatric thyroid disease) require a written directive and the associated procedures.⁶
10 CFR Part 20 — Standards for Protection Against Radiation. Sets the dose framework and ALARA expectations within which pediatric optimization operates.
Consensus guidelines as standard of care. The North American consensus guidelines and the EANM dosage card are not federal law, but they represent the professional standard of care for pediatric dosing; deviating without justification is difficult to defend during accreditation or peer review.¹⁴⁹
Radiopharmaceutical dosimetry references. ICRP Publication 128 provides the biokinetic and dosimetric data used to estimate organ and effective doses from administered activities, supporting the dose side of the optimization.⁷

Agreement States administer their own equivalent medical-use programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use under their own radiation-control rules, while Washington, DC and Delaware are regulated directly by the NRC. A facility should confirm which authority issues its license and document its pediatric dosing methodology accordingly. For the therapy side of pediatric and adult radioiodine work, see I-131 thyroid cancer therapy.

Frequently Asked Questions (FAQs)

How is administered activity determined for children in nuclear medicine?

Administered activity in pediatric nuclear medicine is scaled to body weight using a per-kilogram factor specific to each radiopharmaceutical, then constrained by a minimum activity (and sometimes a maximum). The North American consensus guidelines and the EANM pediatric dosage card provide these factors so that image quality is preserved while dose is minimized for the child's size.

Why do pediatric protocols use a minimum administered activity?

A pure weight-based calculation would give very small infants an activity too low to produce diagnostic images in a reasonable acquisition time. A minimum administered activity ensures that even the smallest patients receive enough counts for an interpretable study, accepting a modestly higher dose per kilogram in exchange for a usable result.

What are the North American consensus guidelines?

They are harmonized recommendations for pediatric administered radiopharmaceutical activities, first published in 2010 and updated in 2016 and 2024 under the Image Gently Alliance. They specify weight-based factors and minimum activities for common pediatric nuclear medicine and PET procedures and are the principal U.S. reference for pediatric dosing.

What changed in the 2024 update of the guidelines?

According to the 2024 update, none of the 23 protocols from the 2016 version were removed, but nine were modified and six new protocols were added—five of them PET agents—reflecting the growing routine use of PET in children. The update addresses advances in imaging equipment, reconstruction, and the introduction of new radiopharmaceuticals.

Are children more sensitive to radiation than adults?

Yes. Children are generally more radiosensitive than adults for stochastic effects, and they have a longer lifetime over which radiation-related effects can manifest. This is why pediatric dose optimization—administering the lowest activity consistent with a diagnostic study—is a central principle of pediatric nuclear medicine.

Do the North American and European guidelines agree?

They were developed separately—the North American consensus guidelines and the EANM pediatric dosage card—but a joint working group harmonized them so that recommended activities are closely aligned for most procedures. Facilities should follow one consistent, current guideline and document their dosing methodology.

Who is responsible for the administered activity in a pediatric study?

The authorized user is responsible for the dosage, supported by the nuclear medicine technologist who prepares and administers it and the medical physicist who helps establish and validate dosing protocols. Under 10 CFR Part 35, diagnostic dosages must be determined and documented, and therapy dosages require a written directive.

Key Takeaways

Weight-based scaling with a minimum. Pediatric administered activity is a per-kilogram factor times body weight, floored at a minimum activity (and sometimes capped at a maximum).¹²
The minimum exists for image quality. Counting statistics dictate that the smallest patients need a floor activity to produce a diagnostic, non-repeated study.³
Follow the current consensus guideline. The North American consensus guidelines—updated in 2024—are the U.S. standard of care, harmonized with the EANM dosage card.¹⁴⁹
PET is growing in children. The 2024 update added six protocols, five of them PET agents, reflecting expanding pediatric PET use.⁴
Optimize the whole study. Pair low activity with modern reconstruction and right-sized CT on hybrid systems, and validate the dose calibrator.⁵
Document within Part 35. Diagnostic dosages must be determined and documented; therapy requires a written directive.⁶

Conclusion

Pediatric nuclear medicine dosing is a disciplined optimization: administer the smallest activity that still yields a diagnostic study for that specific child and procedure. Weight-based scaling delivers size-appropriate dose across the enormous range of pediatric body weights, while the minimum-activity rule—grounded in counting statistics—protects the smallest patients from count-starved, non-diagnostic studies that would only have to be repeated.

The North American consensus guidelines, now in their 2024 update, give North American practices a harmonized, evidence-informed framework that is closely aligned with the EANM dosage card and embedded in the Image Gently philosophy. Facilities that adopt a current guideline, apply it with a validated calculator, optimize the full hybrid-imaging study, and document their methodology within the 10 CFR Part 35 framework deliver consistent, defensible, low-dose pediatric imaging.¹⁴⁶

How DRPS Can Help

Diagnostic Radiation Physics Services helps pediatric and general nuclear medicine programs implement and validate weight-based dosing. That work includes PET/CT and nuclear medicine physics support, pediatric protocol development, dose-calibrator and camera quality control, hybrid-imaging CT optimization, medical physicist consulting, and radiation safety training prepared by board-certified medical physicists.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware. Good pediatric dosing is not about the lowest possible number—it is about the right number for that child, applied consistently and documented well.

Related Resources

References

Treves ST, Gelfand MJ, Fahey FH, Parisi MT. 2016 update of the North American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med. 2016;57(12):15N-18N. PubMed
Treves ST, Fahey FH, Ferrer Valencia V, et al. 2024 update of the North American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med Technol. 2025;53(3):193-197. doi:10.2967/jnmt.125.270161. doi.org
Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med. 2011;52(2):318-322. doi:10.2967/jnumed.110.084327. doi.org
Treves ST, Fahey FH, Ferrer Valencia V, et al. 2024 update of the North American consensus guidelines for pediatric administered radiopharmaceutical activities (Image Gently Alliance). J Nucl Med Technol. 2025;53(3):193-197. doi:10.2967/jnmt.125.270161. snmmi.org
Society of Nuclear Medicine and Molecular Imaging. Pediatric Injected Activity Tool. SNMMI Dose Optimization. snmmi.org
U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov
International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances. ICRP Publication 128. Ann ICRP. 2015;44(2 Suppl). icrp.org
Wildman-Tobriner B, Strauss KJ, Bhargavan-Chatfield M, et al. Using the American College of Radiology Dose Index Registry to evaluate practice patterns and radiation dose estimates of pediatric body CT. AJR Am J Roentgenol. 2018;210(3):641-647. doi:10.2214/AJR.17.18122. doi.org
Lassmann M, Treves ST. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41(5):1036-1041. doi:10.1007/s00259-014-2731-9. doi.org
Lassmann M, Treves ST. Pediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guideline. Eur J Nucl Med Mol Imaging. 2014;41(8):1636. doi:10.1007/s00259-014-2817-4. doi.org